-
Product Insights
TGV Manage Power Plant
TGV Manage Power Plant is a thermal project located in Hainaut, Belgium. The project is owned and being developed by Eneco Holding NV. The project is at the permitting stage. Empower your strategies with our TGV Manage Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
TGV Sraac Gondiparla 3 Solar PV Park
TGV Sraac Gondiparla 3 Solar PV Park is a solar PV project located in Andhra Pradesh, India. The project is owned and being developed by TGV SRAAC Ltd. The project is at the permitting stage. Empower your strategies with our TGV Sraac Gondiparla 3 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Talquetamab in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Talquetamab in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Talquetamab in Multiple Myeloma (Kahler Disease) Drug Details: Talquetamab-tgvs...
-
Product Insights
Skin And Soft Tissue Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Skin And Soft Tissue Infections - Drugs In Development, 2023’, provides an overview of the Skin And Soft Tissue Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Skin And Soft Tissue Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Drugs In Development, 2023’, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Cystic Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cystic Fibrosis - Drugs In Development, 2023’, provides an overview of the Cystic Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cystic Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Drugs In Development, 2023’, provides an overview of the Methicillin-Resistant Staphylococcus aureus (MRSA) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
SNCF – Montpellier to Perpignan TGV Rail Line – Occitania
Equip yourself with the essential tools needed to make informed and profitable decisions with our SNCF - Montpellier to Perpignan TGV Rail Line - Occitania report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
NS Groep NV – Company Profile
NS Groep NV (NS) is a provider of rail and bus transportation services. It operates several high-speed trains such as Thalys, ICE International, Eurostar and TGV. NS also operates NS International Lounges at Amsterdam, Rotterdam, Breda and Schiphol stations. The company carries out the management, operation and development of more than 400 stations and station areas in the Netherlands in cooperation with its partners. The company also provides equipment maintenance services, which include maintenance , cleaning, and refurbishment of rolling...
Add to Basket